Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 215

1.

Vascular endothelial growth factor blockade prevents the beneficial effects of β-blocker therapy on cardiac function, angiogenesis, and remodeling in heart failure.

Rengo G, Cannavo A, Liccardo D, Zincarelli C, de Lucia C, Pagano G, Komici K, Parisi V, Scala O, Agresta A, Rapacciuolo A, Perrone Filardi P, Ferrara N, Koch WJ, Trimarco B, Femminella GD, Leosco D.

Circ Heart Fail. 2013 Nov;6(6):1259-67. doi: 10.1161/CIRCHEARTFAILURE.113.000329. Epub 2013 Sep 12.

2.

Erythropoietin attenuates cardiac dysfunction by increasing myocardial angiogenesis and inhibiting interstitial fibrosis in diabetic rats.

Lu J, Yao YY, Dai QM, Ma GS, Zhang SF, Cao L, Ren LQ, Liu NF.

Cardiovasc Diabetol. 2012 Sep 7;11:105. doi: 10.1186/1475-2840-11-105.

3.

Vascular endothelial growth factor is crucial for erythropoietin-induced improvement of cardiac function in heart failure.

Westenbrink BD, Ruifrok WP, Voors AA, Tilton RG, van Veldhuisen DJ, Schoemaker RG, van Gilst WH, de Boer RA.

Cardiovasc Res. 2010 Jul 1;87(1):30-9. doi: 10.1093/cvr/cvq041. Epub 2010 Feb 5.

PMID:
20139114
4.

Exercise promotes angiogenesis and improves beta-adrenergic receptor signalling in the post-ischaemic failing rat heart.

Leosco D, Rengo G, Iaccarino G, Golino L, Marchese M, Fortunato F, Zincarelli C, Sanzari E, Ciccarelli M, Galasso G, Altobelli GG, Conti V, Matrone G, Cimini V, Ferrara N, Filippelli A, Koch WJ, Rengo F.

Cardiovasc Res. 2008 May 1;78(2):385-94. Epub 2007 Dec 18.

PMID:
18093988
5.

Angiotensin-converting enzyme inhibition promotes coronary angiogenesis in the failing heart of Dahl salt-sensitive hypertensive rats.

Yazawa H, Miyachi M, Furukawa M, Takahashi K, Takatsu M, Tsuboi K, Ohtake M, Murase T, Hattori T, Kato Y, Murohara T, Nagata K.

J Card Fail. 2011 Dec;17(12):1041-50. doi: 10.1016/j.cardfail.2011.09.002. Epub 2011 Oct 17.

PMID:
22123369
6.

Intramyocardial protein therapy with vascular endothelial growth factor (VEGF-165) induces functional angiogenesis in rat senescent myocardium.

Besse S, Boucher F, Linguet G, Riou L, De Leiris J, Riou B, Dimastromatteo J, Comte R, Courty J, Delbe J.

J Physiol Pharmacol. 2010 Dec;61(6):651-61.

7.

Vascular endothelial growth factor blockade promotes the transition from compensatory cardiac hypertrophy to failure in response to pressure overload.

Izumiya Y, Shiojima I, Sato K, Sawyer DB, Colucci WS, Walsh K.

Hypertension. 2006 May;47(5):887-93. Epub 2006 Mar 27.

8.

The impairment of ILK related angiogenesis involved in cardiac maladaptation after infarction.

Xie J, Lu W, Gu R, Dai Q, Zong B, Ling L, Xu B.

PLoS One. 2011;6(9):e24115. doi: 10.1371/journal.pone.0024115. Epub 2011 Sep 16.

9.

Vascular endothelial growth factor promotes cardiac stem cell migration via the PI3K/Akt pathway.

Tang J, Wang J, Kong X, Yang J, Guo L, Zheng F, Zhang L, Huang Y, Wan Y.

Exp Cell Res. 2009 Dec 10;315(20):3521-31. doi: 10.1016/j.yexcr.2009.09.026. Epub 2009 Oct 2.

PMID:
19800880
10.

Complementary therapeutic effects of dual delivery of insulin-like growth factor-1 and vascular endothelial growth factor by gelatin microspheres in experimental heart failure.

Cittadini A, Monti MG, Petrillo V, Esposito G, Imparato G, Luciani A, Urciuolo F, Bobbio E, Natale CF, Saccà L, Netti PA.

Eur J Heart Fail. 2011 Dec;13(12):1264-74. doi: 10.1093/eurjhf/hfr143. Epub 2011 Nov 1.

11.

Transplantation of myoblast sheets that secrete the novel peptide SVVYGLR improves cardiac function in failing hearts.

Uchinaka A, Kawaguchi N, Hamada Y, Mori S, Miyagawa S, Saito A, Sawa Y, Matsuura N.

Cardiovasc Res. 2013 Jul 1;99(1):102-10. doi: 10.1093/cvr/cvt088. Epub 2013 Apr 23.

PMID:
23615564
12.

Selective inhibition of PKCβ2 preserves cardiac function after myocardial infarction and is associated with improved angiogenesis of ischemic myocardium in diabetic rats.

Wang F, Huang D, Zhu W, Li S, Yan M, Wei M, Li J.

Int J Mol Med. 2013 Nov;32(5):1037-46. doi: 10.3892/ijmm.2013.1477. Epub 2013 Aug 28.

PMID:
24002353
13.

Qiliqiangxin improves cardiac function and attenuates cardiac remodeling in rats with experimental myocardial infarction.

Wang J, Zhou J, Ding X, Zhu L, Jiang K, Fu M, Wang S, Hu K, Ge J.

Int J Clin Exp Pathol. 2015 Jun 1;8(6):6596-606. eCollection 2015.

14.

Effects of hydrochlorothiazide on cardiac remodeling in a rat model of myocardial infarction-induced congestive heart failure.

Luo J, Gao X, Peng L, Sun H, Dai G.

Eur J Pharmacol. 2011 Sep 30;667(1-3):314-21. doi: 10.1016/j.ejphar.2011.06.012. Epub 2011 Jun 17.

PMID:
21703256
15.

Effects of spironolactone alone and in addition to a β-blocker on myocardial histological and electrical remodeling in chronic severe failing rat hearts.

Milliez P, Gomes S, Champ-Rigot L, Callebert J, Samuel JL, Delcayre C.

J Cardiovasc Pharmacol. 2012 Sep;60(3):315-21. doi: 10.1097/FJC.0b013e318260e688.

PMID:
22710814
16.

Adaptive response of the heart to long-term anemia induced by iron deficiency.

Naito Y, Tsujino T, Matsumoto M, Sakoda T, Ohyanagi M, Masuyama T.

Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H585-93. doi: 10.1152/ajpheart.00463.2008. Epub 2009 Jan 9.

17.

Postinfarct treatment with oxytocin improves cardiac function and remodeling via activating cell-survival signals and angiogenesis.

Kobayashi H, Yasuda S, Bao N, Iwasa M, Kawamura I, Yamada Y, Yamaki T, Sumi S, Ushikoshi H, Nishigaki K, Takemura G, Fujiwara T, Fujiwara H, Minatoguchi S.

J Cardiovasc Pharmacol. 2009 Dec;54(6):510-9. doi: 10.1097/FJC.0b013e3181bfac02.

PMID:
19755919
18.

Mesenchymal stem cells over-expressing SDF-1 promote angiogenesis and improve heart function in experimental myocardial infarction in rats.

Tang J, Wang J, Yang J, Kong X, Zheng F, Guo L, Zhang L, Huang Y.

Eur J Cardiothorac Surg. 2009 Oct;36(4):644-50. doi: 10.1016/j.ejcts.2009.04.052. Epub 2009 Jun 12.

PMID:
19524448
19.

A relationship between vascular endothelial growth factor, angiogenesis, and cardiac repair after muscle stem cell transplantation into ischemic hearts.

Payne TR, Oshima H, Okada M, Momoi N, Tobita K, Keller BB, Peng H, Huard J.

J Am Coll Cardiol. 2007 Oct 23;50(17):1677-84.

20.

Resveratrol ameliorates myocardial damage by inducing vascular endothelial growth factor-angiogenesis and tyrosine kinase receptor Flk-1.

Fukuda S, Kaga S, Zhan L, Bagchi D, Das DK, Bertelli A, Maulik N.

Cell Biochem Biophys. 2006;44(1):43-9.

PMID:
16456233

Supplemental Content

Support Center